Geron's protocol enhances stem-cell yield:........ 'What we're suggesting here is we have a good uniform, plentiful supply of clean, young functional islet cells,' David Greenwood, Geron's executive vice president and chief financial officer, told United Press International.
...'Science is great, but it's got to be translational into a viable product,' Greenwood said, noting that the efficiency of this protocol pushes them closer to that goal. ...This might not be the final protocol Geron uses to produce a commercial product, 'but this is a big (step),' he said. 'This is the first time we're saying we think we have a therapeutic cell.' ...Geron, which presented the protocol at the Stem Cells & Regenerative Medicine Meeting in San Francisco, said in a statement that animal studies using islet cells made by the new method are currently underway at the University of Alberta in Edmonton, Canada.....[MORE]"